We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,467
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPF icon
14576
AppFolio
APPF
$7.17B
-4,382
Closed -$529K
APRE icon
14577
CALL
Aprea Therapeutics
APRE
$8.42M
-16,115
Closed -$104K
APRE icon
14578
Aprea Therapeutics
APRE
$8.42M
-64
Closed -$411
APRE icon
14579
PUT
Aprea Therapeutics
APRE
$8.42M
-585
Closed -$3.77K
APVO icon
14580
Aptevo Therapeutics
APVO
$4.49M
0
-$97.6K
AQMS icon
14581
Aqua Metals
AQMS
$9.78M
-2
Closed -$467
AQST icon
14582
Aquestive Therapeutics
AQST
$531M
-2,910
Closed -$2.52K
ARMP icon
14583
Armata Pharmaceuticals
ARMP
$169M
-12,162
Closed -$15.1K
ASA
14584
ASA Gold and Precious Metals
ASA
$1.1B
-2,031
Closed -$31.3K
CVSA
14585
CALL
Covista Inc
CVSA
$4.49B
-4,600
Closed -$163K
CVSA
14586
Covista Inc
CVSA
$4.49B
-45,597
Closed -$1.62M
CVSA
14587
PUT
Covista Inc
CVSA
$4.49B
-3,500
Closed -$124K
ATOS icon
14588
Atossa Therapeutics
ATOS
$25.5M
-4,740
Closed -$52.9K
ATXG icon
14589
Addentax Group
ATXG
$4.28M
-95
Closed -$15K
AUB icon
14590
Atlantic Union Bankshares
AUB
$6.13B
-16,223
Closed -$600K
AUUDW
14591
DELISTED
Auddia Inc Warrants
AUUDW
-13,911
Closed -$2.23K
AVAH icon
14592
CALL
Aveanna Healthcare
AVAH
$2.7B
-9,600
Closed -$7.49K
AVAH icon
14593
Aveanna Healthcare
AVAH
$2.7B
-81,948
Closed -$63.9K
AVAH icon
14594
PUT
Aveanna Healthcare
AVAH
$2.7B
-2,500
Closed -$1.95K
AVDE icon
14595
Avantis International Equity ETF
AVDE
$18.8B
-349,517
Closed -$19.7M
AVES icon
14596
Avantis Emerging Markets Value ETF
AVES
$1.49B
-29,192
Closed -$1.2M
AVNW icon
14597
Aviat Networks
AVNW
$286M
-36,928
Closed -$1.26M
JBIO
14598
Jade Biosciences
JBIO
$1.57B
-44,626
Closed -$45.8M
AWP
14599
abrdn Global Premier Properties Fund
AWP
$366M
-4,018
Closed -$47K
AXDX
14600
DELISTED
Accelerate Diagnostics
AXDX
-912
Closed -$5.48K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,467 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.